Version 2.78

Description

Barbiturates were first developed in 1864 by Adolf von Baeyer and were widely distributed by the Farbwerke Fr Bayer and Co in 1904. Barbiturates offered new treatment to patients with psychiatric and neurological disorders profoundly improving their prognoses. Barbiturates were also used to treat sleep disorders and were the first drugs to effectively treat epileptic seizures. Due to safety concerns related to drug dependence and overdose and new safer psychoactive medications barbiturate use sharply declined in the 1950s. PMCID: PMC2424120 Pentobarbital is a short-acting barbiturate that is used as a sedative, a hypnotic and to induce sleep. [PubChem: pentobarbital] Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
PENTobarbital
Part Type
Component (Describes the core component or analyte measured)
Created On
2000-05-04
Construct for LOINC Short Name
Pentobarb

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP16241-9
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP16241-9

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 戊巴比妥
fr-CA French (Canada) Pentobarbital
et-EE Estonian (Estonia) Pentobarbitaal
es-ES Spanish (Spain) Pentobarbital
it-IT Italian (Italy) Pentobarbitale
tr-TR Turkish (Turkey) Pentobarbital
ru-RU Russian (Russian Federation) Пентобарбитал
nl-NL Dutch (Netherlands) pentobarbital
fr-BE French (Belgium) Pentobarbital